世界の糖尿病性胃不全麻痺治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Diabetic Gastroparesis Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z1831 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥553,800 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥830,700 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,107,600 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、糖尿病性胃不全麻痺治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（医薬品、手術治療製品）、用途別市場規模（病院薬局、民間クリニック、ドラッグストア、Eコマース）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・糖尿病性胃不全麻痺治療の市場動向 ・企業の競争状況、市場シェア ・糖尿病性胃不全麻痺治療の種類別市場規模（医薬品、手術治療製品） ・糖尿病性胃不全麻痺治療の用途別市場規模（病院薬局、民間クリニック、ドラッグストア、Eコマース） ・糖尿病性胃不全麻痺治療の北米市場規模2016-2027（アメリカ、カナダ） ・糖尿病性胃不全麻痺治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・糖尿病性胃不全麻痺治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・糖尿病性胃不全麻痺治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・糖尿病性胃不全麻痺治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Sumitomo、Johnson & Johnson、Sanofi、Medtronic、Pfizer、Teva、Boston Scientific） ・結論

Diabetic gastroparesis refers to cases of the digestive condition gastroparesis that diabetes causes.

During normal digestion, the stomach contracts to help break down food and move it into the small intestine. Gastroparesis disrupts the stomach’s contraction, which can interrupt digestion. Diabetes can cause gastroparesis due to its effects on the nervous system.

Both type 1 diabetes and type 2 diabetes can cause nerve damage. One of the nerves diabetes may damage is the vagus nerve. The vagus nerve controls the movement of food through the stomach. When the vagus nerve experiences damage, the muscles in the stomach and other parts of the digestive tract are not able to function properly. When this happens, food cannot move as quickly through the digestive system. Gastroparesis is also known as delayed gastric emptying.
Market is not concentrated. Sumitomo, Johnson & Johnson, Sanofi are the leaders of the industry, and hold the key technologies and patent, with high-end customers. Top 3 manufacturer accounted for 7.4% market share in 2019.

Market Analysis and Insights: Global Diabetic Gastroparesis Treatment Market
The global Diabetic Gastroparesis Treatment market size is projected to reach US$ 4526.3 million by 2026, from US$ 3049 million in 2019, at a CAGR of 5.9% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Diabetic Gastroparesis Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Diabetic Gastroparesis Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Diabetic Gastroparesis Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Diabetic Gastroparesis Treatment market.

Global Diabetic Gastroparesis Treatment Scope and Market Size
Diabetic Gastroparesis Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Diabetic Gastroparesis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Drugs
Surgical Treatment Products
The classification of Diabetic Gastroparesis Treatment includes drugs and Surgical Treatment Products. The proportion of Diabetic Gastroparesis drugs in 2019 is about 62.91%.

Segment by Application
Hospital Pharmacies
Private Clinics
Drug Stores
E-Commerce
The application of Diabetic Gastroparesis Treatment includes Hospital Pharmacies, Private Clinics, Drug Stores and E-Commerce. The proportion of hospital pharmacies in 2019 is about 26.83%.

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Sumitomo
Johnson & Johnson
Sanofi
Medtronic
Pfizer
Teva
Boston Scientific

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diabetic Gastroparesis Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Drugs
1.2.3 Surgical Treatment Products
1.3 Market by Application
1.3.1 Global Diabetic Gastroparesis Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Private Clinics
1.3.4 Drug Stores
1.3.5 E-Commerce
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Diabetic Gastroparesis Treatment Market Perspective (2016-2027)
2.2 Diabetic Gastroparesis Treatment Growth Trends by Regions
2.2.1 Diabetic Gastroparesis Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Diabetic Gastroparesis Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Diabetic Gastroparesis Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Diabetic Gastroparesis Treatment Industry Dynamic
2.3.1 Diabetic Gastroparesis Treatment Market Trends
2.3.2 Diabetic Gastroparesis Treatment Market Drivers
2.3.3 Diabetic Gastroparesis Treatment Market Challenges
2.3.4 Diabetic Gastroparesis Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Diabetic Gastroparesis Treatment Players by Revenue
3.1.1 Global Top Diabetic Gastroparesis Treatment Players by Revenue (2016-2021)
3.1.2 Global Diabetic Gastroparesis Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Diabetic Gastroparesis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Diabetic Gastroparesis Treatment Revenue
3.4 Global Diabetic Gastroparesis Treatment Market Concentration Ratio
3.4.1 Global Diabetic Gastroparesis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diabetic Gastroparesis Treatment Revenue in 2020
3.5 Diabetic Gastroparesis Treatment Key Players Head office and Area Served
3.6 Key Players Diabetic Gastroparesis Treatment Product Solution and Service
3.7 Date of Enter into Diabetic Gastroparesis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Diabetic Gastroparesis Treatment Breakdown Data by Type
4.1 Global Diabetic Gastroparesis Treatment Historic Market Size by Type (2016-2021)
4.2 Global Diabetic Gastroparesis Treatment Forecasted Market Size by Type (2022-2027)

5 Diabetic Gastroparesis Treatment Breakdown Data by Application
5.1 Global Diabetic Gastroparesis Treatment Historic Market Size by Application (2016-2021)
5.2 Global Diabetic Gastroparesis Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Diabetic Gastroparesis Treatment Market Size (2016-2027)
6.2 North America Diabetic Gastroparesis Treatment Market Size by Type
6.2.1 North America Diabetic Gastroparesis Treatment Market Size by Type (2016-2021)
6.2.2 North America Diabetic Gastroparesis Treatment Market Size by Type (2022-2027)
6.2.3 North America Diabetic Gastroparesis Treatment Market Size by Type (2016-2027)
6.3 North America Diabetic Gastroparesis Treatment Market Size by Application
6.3.1 North America Diabetic Gastroparesis Treatment Market Size by Application (2016-2021)
6.3.2 North America Diabetic Gastroparesis Treatment Market Size by Application (2022-2027)
6.3.3 North America Diabetic Gastroparesis Treatment Market Size by Application (2016-2027)
6.4 North America Diabetic Gastroparesis Treatment Market Size by Country
6.4.1 North America Diabetic Gastroparesis Treatment Market Size by Country (2016-2021)
6.4.2 North America Diabetic Gastroparesis Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Diabetic Gastroparesis Treatment Market Size (2016-2027)
7.2 Europe Diabetic Gastroparesis Treatment Market Size by Type
7.2.1 Europe Diabetic Gastroparesis Treatment Market Size by Type (2016-2021)
7.2.2 Europe Diabetic Gastroparesis Treatment Market Size by Type (2022-2027)
7.2.3 Europe Diabetic Gastroparesis Treatment Market Size by Type (2016-2027)
7.3 Europe Diabetic Gastroparesis Treatment Market Size by Application
7.3.1 Europe Diabetic Gastroparesis Treatment Market Size by Application (2016-2021)
7.3.2 Europe Diabetic Gastroparesis Treatment Market Size by Application (2022-2027)
7.3.3 Europe Diabetic Gastroparesis Treatment Market Size by Application (2016-2027)
7.4 Europe Diabetic Gastroparesis Treatment Market Size by Country
7.4.1 Europe Diabetic Gastroparesis Treatment Market Size by Country (2016-2021)
7.4.2 Europe Diabetic Gastroparesis Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Diabetic Gastroparesis Treatment Market Size (2016-2027)
8.2 Asia-Pacific Diabetic Gastroparesis Treatment Market Size by Type
8.2.1 Asia-Pacific Diabetic Gastroparesis Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Diabetic Gastroparesis Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Diabetic Gastroparesis Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Diabetic Gastroparesis Treatment Market Size by Application
8.3.1 Asia-Pacific Diabetic Gastroparesis Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Diabetic Gastroparesis Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Diabetic Gastroparesis Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Diabetic Gastroparesis Treatment Market Size by Region
8.4.1 Asia-Pacific Diabetic Gastroparesis Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Diabetic Gastroparesis Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Diabetic Gastroparesis Treatment Market Size (2016-2027)
9.2 Latin America Diabetic Gastroparesis Treatment Market Size by Type
9.2.1 Latin America Diabetic Gastroparesis Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Diabetic Gastroparesis Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Diabetic Gastroparesis Treatment Market Size by Type (2016-2027)
9.3 Latin America Diabetic Gastroparesis Treatment Market Size by Application
9.3.1 Latin America Diabetic Gastroparesis Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Diabetic Gastroparesis Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Diabetic Gastroparesis Treatment Market Size by Application (2016-2027)
9.4 Latin America Diabetic Gastroparesis Treatment Market Size by Country
9.4.1 Latin America Diabetic Gastroparesis Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Diabetic Gastroparesis Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Diabetic Gastroparesis Treatment Market Size (2016-2027)
10.2 Middle East & Africa Diabetic Gastroparesis Treatment Market Size by Type
10.2.1 Middle East & Africa Diabetic Gastroparesis Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Diabetic Gastroparesis Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Diabetic Gastroparesis Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Diabetic Gastroparesis Treatment Market Size by Application
10.3.1 Middle East & Africa Diabetic Gastroparesis Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Diabetic Gastroparesis Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Diabetic Gastroparesis Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Diabetic Gastroparesis Treatment Market Size by Country
10.4.1 Middle East & Africa Diabetic Gastroparesis Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Diabetic Gastroparesis Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Sumitomo
11.1.1 Sumitomo Company Details
11.1.2 Sumitomo Business Overview
11.1.3 Sumitomo Diabetic Gastroparesis Treatment Introduction
11.1.4 Sumitomo Revenue in Diabetic Gastroparesis Treatment Business (2016-2021)
11.1.5 Sumitomo Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Diabetic Gastroparesis Treatment Introduction
11.2.4 Johnson & Johnson Revenue in Diabetic Gastroparesis Treatment Business (2016-2021)
11.2.5 Johnson & Johnson Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Diabetic Gastroparesis Treatment Introduction
11.3.4 Sanofi Revenue in Diabetic Gastroparesis Treatment Business (2016-2021)
11.3.5 Sanofi Recent Development
11.4 Medtronic
11.4.1 Medtronic Company Details
11.4.2 Medtronic Business Overview
11.4.3 Medtronic Diabetic Gastroparesis Treatment Introduction
11.4.4 Medtronic Revenue in Diabetic Gastroparesis Treatment Business (2016-2021)
11.4.5 Medtronic Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Diabetic Gastroparesis Treatment Introduction
11.5.4 Pfizer Revenue in Diabetic Gastroparesis Treatment Business (2016-2021)
11.5.5 Pfizer Recent Development
11.6 Teva
11.6.1 Teva Company Details
11.6.2 Teva Business Overview
11.6.3 Teva Diabetic Gastroparesis Treatment Introduction
11.6.4 Teva Revenue in Diabetic Gastroparesis Treatment Business (2016-2021)
11.6.5 Teva Recent Development
11.7 Boston Scientific
11.7.1 Boston Scientific Company Details
11.7.2 Boston Scientific Business Overview
11.7.3 Boston Scientific Diabetic Gastroparesis Treatment Introduction
11.7.4 Boston Scientific Revenue in Diabetic Gastroparesis Treatment Business (2016-2021)
11.7.5 Boston Scientific Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Diabetic Gastroparesis Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Drugs
Table 3. Key Players of Surgical Treatment Products
Table 4. Global Diabetic Gastroparesis Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Diabetic Gastroparesis Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Diabetic Gastroparesis Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Diabetic Gastroparesis Treatment Market Share by Regions (2016-2021)
Table 8. Global Diabetic Gastroparesis Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Diabetic Gastroparesis Treatment Market Share by Regions (2022-2027)
Table 10. Diabetic Gastroparesis Treatment Market Trends
Table 11. Diabetic Gastroparesis Treatment Market Drivers
Table 12. Diabetic Gastroparesis Treatment Market Challenges
Table 13. Diabetic Gastroparesis Treatment Market Restraints
Table 14. Global Diabetic Gastroparesis Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Diabetic Gastroparesis Treatment Market Share by Players (2016-2021)
Table 16. Global Top Diabetic Gastroparesis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetic Gastroparesis Treatment as of 2020)
Table 17. Ranking of Global Top Diabetic Gastroparesis Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Diabetic Gastroparesis Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Diabetic Gastroparesis Treatment Product Solution and Service
Table 21. Date of Enter into Diabetic Gastroparesis Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Diabetic Gastroparesis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Diabetic Gastroparesis Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Diabetic Gastroparesis Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Diabetic Gastroparesis Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Diabetic Gastroparesis Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Diabetic Gastroparesis Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Diabetic Gastroparesis Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Diabetic Gastroparesis Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Diabetic Gastroparesis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Diabetic Gastroparesis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Diabetic Gastroparesis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Diabetic Gastroparesis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Diabetic Gastroparesis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Diabetic Gastroparesis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Diabetic Gastroparesis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Diabetic Gastroparesis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Diabetic Gastroparesis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Diabetic Gastroparesis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Diabetic Gastroparesis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Diabetic Gastroparesis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Diabetic Gastroparesis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Diabetic Gastroparesis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Diabetic Gastroparesis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Diabetic Gastroparesis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Diabetic Gastroparesis Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Diabetic Gastroparesis Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Diabetic Gastroparesis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Diabetic Gastroparesis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Diabetic Gastroparesis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Diabetic Gastroparesis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Diabetic Gastroparesis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Diabetic Gastroparesis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Diabetic Gastroparesis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Diabetic Gastroparesis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Diabetic Gastroparesis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Diabetic Gastroparesis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Diabetic Gastroparesis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Diabetic Gastroparesis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Sumitomo Company Details
Table 62. Sumitomo Business Overview
Table 63. Sumitomo Diabetic Gastroparesis Treatment Product
Table 64. Sumitomo Revenue in Diabetic Gastroparesis Treatment Business (2016-2021) & (US$ Million)
Table 65. Sumitomo Recent Development
Table 66. Johnson & Johnson Company Details
Table 67. Johnson & Johnson Business Overview
Table 68. Johnson & Johnson Diabetic Gastroparesis Treatment Product
Table 69. Johnson & Johnson Revenue in Diabetic Gastroparesis Treatment Business (2016-2021) & (US$ Million)
Table 70. Johnson & Johnson Recent Development
Table 71. Sanofi Company Details
Table 72. Sanofi Business Overview
Table 73. Sanofi Diabetic Gastroparesis Treatment Product
Table 74. Sanofi Revenue in Diabetic Gastroparesis Treatment Business (2016-2021) & (US$ Million)
Table 75. Sanofi Recent Development
Table 76. Medtronic Company Details
Table 77. Medtronic Business Overview
Table 78. Medtronic Diabetic Gastroparesis Treatment Product
Table 79. Medtronic Revenue in Diabetic Gastroparesis Treatment Business (2016-2021) & (US$ Million)
Table 80. Medtronic Recent Development
Table 81. Pfizer Company Details
Table 82. Pfizer Business Overview
Table 83. Pfizer Diabetic Gastroparesis Treatment Product
Table 84. Pfizer Revenue in Diabetic Gastroparesis Treatment Business (2016-2021) & (US$ Million)
Table 85. Pfizer Recent Development
Table 86. Teva Company Details
Table 87. Teva Business Overview
Table 88. Teva Diabetic Gastroparesis Treatment Product
Table 89. Teva Revenue in Diabetic Gastroparesis Treatment Business (2016-2021) & (US$ Million)
Table 90. Teva Recent Development
Table 91. Boston Scientific Company Details
Table 92. Boston Scientific Business Overview
Table 93. Boston Scientific Diabetic Gastroparesis Treatment Product
Table 94. Boston Scientific Revenue in Diabetic Gastroparesis Treatment Business (2016-2021) & (US$ Million)
Table 95. Boston Scientific Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Diabetic Gastroparesis Treatment Market Share by Type: 2020 VS 2027
Figure 2. Drugs Features
Figure 3. Surgical Treatment Products Features
Figure 4. Global Diabetic Gastroparesis Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospital Pharmacies Case Studies
Figure 6. Private Clinics Case Studies
Figure 7. Drug Stores Case Studies
Figure 8. E-Commerce Case Studies
Figure 9. Diabetic Gastroparesis Treatment Report Years Considered
Figure 10. Global Diabetic Gastroparesis Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Diabetic Gastroparesis Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Diabetic Gastroparesis Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Diabetic Gastroparesis Treatment Market Share by Regions (2022-2027)
Figure 14. Global Diabetic Gastroparesis Treatment Market Share by Players in 2020
Figure 15. Global Top Diabetic Gastroparesis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetic Gastroparesis Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Diabetic Gastroparesis Treatment Revenue in 2020
Figure 17. Global Diabetic Gastroparesis Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Diabetic Gastroparesis Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Diabetic Gastroparesis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Diabetic Gastroparesis Treatment Market Share by Type (2016-2027)
Figure 21. North America Diabetic Gastroparesis Treatment Market Share by Application (2016-2027)
Figure 22. North America Diabetic Gastroparesis Treatment Market Share by Country (2016-2027)
Figure 23. United States Diabetic Gastroparesis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Diabetic Gastroparesis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Diabetic Gastroparesis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Diabetic Gastroparesis Treatment Market Share by Type (2016-2027)
Figure 27. Europe Diabetic Gastroparesis Treatment Market Share by Application (2016-2027)
Figure 28. Europe Diabetic Gastroparesis Treatment Market Share by Country (2016-2027)
Figure 29. Germany Diabetic Gastroparesis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Diabetic Gastroparesis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Diabetic Gastroparesis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Diabetic Gastroparesis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Diabetic Gastroparesis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Diabetic Gastroparesis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Diabetic Gastroparesis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Diabetic Gastroparesis Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Diabetic Gastroparesis Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Diabetic Gastroparesis Treatment Market Share by Region (2016-2027)
Figure 39. China Diabetic Gastroparesis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Diabetic Gastroparesis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Diabetic Gastroparesis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Diabetic Gastroparesis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Diabetic Gastroparesis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Diabetic Gastroparesis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Diabetic Gastroparesis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Diabetic Gastroparesis Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Diabetic Gastroparesis Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Diabetic Gastroparesis Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Diabetic Gastroparesis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Diabetic Gastroparesis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Diabetic Gastroparesis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Diabetic Gastroparesis Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Diabetic Gastroparesis Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Diabetic Gastroparesis Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Diabetic Gastroparesis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Diabetic Gastroparesis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Diabetic Gastroparesis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Sumitomo Revenue Growth Rate in Diabetic Gastroparesis Treatment Business (2016-2021)
Figure 59. Johnson & Johnson Revenue Growth Rate in Diabetic Gastroparesis Treatment Business (2016-2021)
Figure 60. Sanofi Revenue Growth Rate in Diabetic Gastroparesis Treatment Business (2016-2021)
Figure 61. Medtronic Revenue Growth Rate in Diabetic Gastroparesis Treatment Business (2016-2021)
Figure 62. Pfizer Revenue Growth Rate in Diabetic Gastroparesis Treatment Business (2016-2021)
Figure 63. Teva Revenue Growth Rate in Diabetic Gastroparesis Treatment Business (2016-2021)
Figure 64. Boston Scientific Revenue Growth Rate in Diabetic Gastroparesis Treatment Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

---